Home › Compugen Discloses New Results For Novel Target Candidate For Cancer Immunotherapy
 

Keywords :   


Compugen Discloses New Results For Novel Target Candidate For Cancer Immunotherapy

2014-10-01 14:07:35| drugdiscoveryonline Home Page

Compugen Ltd. recently disclosed results from recent studies further confirming CGEN-15049 as a promising target candidate for cancer immunotherapy. These recent studies evaluated the function of this Compugen-discovered immune checkpoint candidate on immune cells derived from the tumor environment of melanoma patients

Tags: results target cancer candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
28.06Tropical Depression Two Forecast Discussion Number 1
28.06Tropical Depression Two Wind Speed Probabilities Number 1
More »